Wednesday, December 15, 2010

Galderma Pharma launches $970-million bid for cosmetic treatment firm Q-Med

Bengt Agerup, the founder of Q-Med, who holds 47.5 per cent stake in the company, has accepted the offer of 58.94 kronor a share, and will receive additional 16.02 kronor a share for a total of 74.96 kronor a share if certain financial and business goals are met.
The deal would make him richer by around 3 to 3.5 billion kronor (approx $500 million).

1 comment:

Tumor In Lung said...

Thanks for the great work. Many, many thanks.